Michael Portman: Clinical Trials

2 trials sponsored by Michael Portman, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Michael Portman: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease
Etanercept, Placebo - Mucocutaneous Lymph Node Syndrome, Kawasaki Disease
Phase 2CompletedMichael Portman2052009-03-012023-05-06
Study of Triostat in Infants During Heart Surgery
Liothyronine sodium/triiodothyronine, Cardiopulmonary bypass and cardiac surgery - Heart Defects, Congenital
Phase 3CompletedMichael Portman1952001-04-012013-08-05

Conditions studied

Endocardial Cushion Defects (1)  ·  Heart Defects, Congenital (1)  ·  Hypoplastic Left Heart Syndrome (1)  ·  Mucocutaneous Lymph Node Syndrome (1)

Interventions

Cardiac Surgical Procedures (1)  ·  Cardiopulmonary Bypass (1)  ·  Etanercept (1)  ·  Triiodothyronine (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Michael A Portman, MD (1)

Results publications

PMID 20837917, PMID 31048415, PMID 35545881